Developer docs
API playgroundTry for free, no card

Search company profiles

Ecolyse

Full company profile

uuid000nab7

Namestring
Ecolyse
Websiteurl
ecolyse.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Ecolyse is a privately-held biotechnology firm founded in 2007 and headquartered in College Station, Texas. According to available firmographic data, the company develops microbiological products and services for clients operating in three distinct verticals: the energy sector, the industrial sector, and the health sector. Its functional positioning sits at the intersection of applied microbiology and industrial bioprocessing, suggesting a B2B technology-and-services model rather than a consumer-facing offering.

Detailed information on Ecolyse's specific product portfolio, service lines, go-to-market motion, pricing mechanics, customer profile, and revenue model is not available in the supplied input. The company's public website (ecolyse.com) currently displays a verification/loading page rather than substantive corporate or technical content, and no management team bios, customer logos, partnership announcements, patent disclosures, certification details, or product specifications were captured in the source material. The only documented financial event in the data is a July 2012 funding round of $821,515 from the National Science Foundation, consistent with a non-dilutive, R&D-oriented funding posture typical of early-stage SBIR/STTR-style recipients.

Ecolyse is classified as a small for-profit private company with 11-50 employees. Given the absence of any more recent disclosed funding event, product launch, leadership change, partnership, or commercial milestone in the input, the available evidence is insufficient to characterize current commercial traction, revenue trajectory, or operating status with confidence. The 12+ year gap since the last documented financing event and the non-functional corporate website are themselves material data points for any diligence process.

Short descriptiontext

Ecolyse is a privately-held biotechnology firm founded in 2007 in College Station, Texas, developing microbiological products and services for the energy, industrial, and health sectors. Available data is limited; the only documented financing is a 2012 NSF grant.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCollege Station, United States
HQ citystring
College Station
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
microbial bioremediation, industrial microbiology, biological treatment services, microbiological products, environmental biotech solutions
Industry1 code
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Industrial Microbiology / Bioremediation
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ecolyse offers microbiological products and services for the energy, industrial, and health sectors. The company develops and delivers biological/microbe-based solutions applicable across energy, industrial, and healthcare markets, leveraging microbial science to address sector-specific needs.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Microbiological Products and Services
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in industrial enzymes and microbial solutions across energy, agriculture, and health. Highly comparable as a broad incumbent supplying microbiological inputs into the same verticals Ecolyse targets, but at vastly greater scale and product breadth.

TypeEmerging player
Description

CDMO specializing in microbial fermentation and biologics manufacturing for health and industrial customers. Comparable as a similarly sized contract manufacturer using microbiological processes for health and industrial applications.

TypeEmerging player
Description

Developer of engineered microbial therapeutics (phage- and bacteria-based) for microbiome-related health applications. Comparable as an emerging player building microbial products aimed at the health sector mentioned in Ecolyse's offering.

TypeOthers
Description

Industrial biotech company using engineered microbes to produce ingredients for health, beauty, and clean energy markets. Highly comparable in its use of microbial fermentation to serve health and energy verticals, though currently undergoing a corporate restructuring.

5Zymergen (now part of Ginkgo Bioworks)
TypeEmerging player
Description

Historically a synthetic biology company using engineered microbes for industrial applications; now integrated into Ginkgo. Comparable as a developer of microbiological solutions spanning industrial and consumer verticals.

TypeDirect peer
Description

Engineers enzymes and microbial strains for industrial bioprocessing applications across pharmaceuticals, food, and sustainable chemicals. Directly comparable as a developer of microbial/enzymatic inputs sold into industrial and health-adjacent end markets.

TypeBroad incumbent
Description

Global ingredient company with extensive industrial biotechnology and microbiome/health portfolios. Comparable as a broad incumbent serving health, food, and industrial end markets with fermentation-derived products.

TypeBroad incumbent
Description

Major ingredients producer (now including the former DuPont Industrial Biosciences) with a large microbial and enzyme portfolio for energy, industrial, and consumer health applications. Comparable as a broad incumbent with overlapping microbial product lines.

TypeBroad incumbent
Description

Horizontal synthetic biology platform that programs microbial strains for diverse industrial applications, including energy, health, and industrial biotech. Comparable as a broad incumbent platform with overlapping end markets and similar enabling technology.

TypeDirect peer
Description

Develops gas-fermenting microbes that convert industrial off-gases into fuels and chemicals for the energy sector. Directly comparable to Ecolyse's energy-focused microbiological products and similar in its use of engineered microbial platforms.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ecolyse

Industrial Microbiology / Bioremediationecolyse.com

Ecolyse is a privately-held biotechnology firm founded in 2007 in College Station, Texas, developing microbiological products and services for the energy, industrial, and health sectors. Available data is limited; the only documented financing is a 2012 NSF grant.

What Ecolyse does

Ecolyse is a privately-held biotechnology firm founded in 2007 and headquartered in College Station, Texas. According to available firmographic data, the company develops microbiological products and services for clients operating in three distinct verticals: the energy sector, the industrial sector, and the health sector. Its functional positioning sits at the intersection of applied microbiology and industrial bioprocessing, suggesting a B2B technology-and-services model rather than a consumer-facing offering.

Detailed information on Ecolyse's specific product portfolio, service lines, go-to-market motion, pricing mechanics, customer profile, and revenue model is not available in the supplied input. The company's public website (ecolyse.com) currently displays a verification/loading page rather than substantive corporate or technical content, and no management team bios, customer logos, partnership announcements, patent disclosures, certification details, or product specifications were captured in the source material. The only documented financial event in the data is a July 2012 funding round of $821,515 from the National Science Foundation, consistent with a non-dilutive, R&D-oriented funding posture typical of early-stage SBIR/STTR-style recipients.

Ecolyse is classified as a small for-profit private company with 11-50 employees. Given the absence of any more recent disclosed funding event, product launch, leadership change, partnership, or commercial milestone in the input, the available evidence is insufficient to characterize current commercial traction, revenue trajectory, or operating status with confidence. The 12+ year gap since the last documented financing event and the non-functional corporate website are themselves material data points for any diligence process.

Ecolyse firmographics

Firmographics
Name
Ecolyse
Website
https://ecolyse.com
Company type
Private
Founded year
2007
Headcount range
11–50 employees
Short description
Ecolyse is a privately-held biotechnology firm founded in 2007 in College Station, Texas, developing microbiological products and services for the energy, industrial, and health sectors. Available data is limited; the only documented financing is a 2012 NSF grant.
Ownership category
akta.pro rank

Ecolyse industry classification

Industry
Product category
Industrial Microbiology / Bioremediation
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Microbial bioremediation
  • Industrial microbiology
  • Biological treatment services
  • Microbiological products
  • Environmental biotech solutions

Where Ecolyse is headquartered

Location

Headquarters

HQ city
College Station
HQ country
United States
HQ region
North America

Markets served

Ecolyse business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Ecolyse product offering

Product offering

Core offering

Ecolyse offers microbiological products and services for the energy, industrial, and health sectors. The company develops and delivers biological/microbe-based solutions applicable across energy, industrial, and healthcare markets, leveraging microbial science to address sector-specific needs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Microbiological Products and Services

Companies that use Ecolyse

Customer profile

Ideal customer profiles3 records

Ecolyse technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Ecolyse partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights2 records

Ecolyse competitors and assessment

Company assessment

Broad incumbents

  • Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial solutions across energy, agriculture, and health. Highly comparable as a broad incumbent supplying microbiological inputs into the same verticals Ecolyse targets, but at vastly greater scale and product breadth.
  • DSM-Firmenich: Global ingredient company with extensive industrial biotechnology and microbiome/health portfolios. Comparable as a broad incumbent serving health, food, and industrial end markets with fermentation-derived products.
  • IFF (International Flavors & Fragrances): Major ingredients producer (now including the former DuPont Industrial Biosciences) with a large microbial and enzyme portfolio for energy, industrial, and consumer health applications. Comparable as a broad incumbent with overlapping microbial product lines.
  • Ginkgo Bioworks: Horizontal synthetic biology platform that programs microbial strains for diverse industrial applications, including energy, health, and industrial biotech. Comparable as a broad incumbent platform with overlapping end markets and similar enabling technology.

Emerging players

  • BioVectra: CDMO specializing in microbial fermentation and biologics manufacturing for health and industrial customers. Comparable as a similarly sized contract manufacturer using microbiological processes for health and industrial applications.
  • Eligo Bioscience: Developer of engineered microbial therapeutics (phage- and bacteria-based) for microbiome-related health applications. Comparable as an emerging player building microbial products aimed at the health sector mentioned in Ecolyse's offering.
  • Zymergen (now part of Ginkgo Bioworks): Historically a synthetic biology company using engineered microbes for industrial applications; now integrated into Ginkgo. Comparable as a developer of microbiological solutions spanning industrial and consumer verticals.

Others

  • Amyris: Industrial biotech company using engineered microbes to produce ingredients for health, beauty, and clean energy markets. Highly comparable in its use of microbial fermentation to serve health and energy verticals, though currently undergoing a corporate restructuring.

Direct peers

  • Codexis: Engineers enzymes and microbial strains for industrial bioprocessing applications across pharmaceuticals, food, and sustainable chemicals. Directly comparable as a developer of microbial/enzymatic inputs sold into industrial and health-adjacent end markets.
  • LanzaTech: Develops gas-fermenting microbes that convert industrial off-gases into fuels and chemicals for the energy sector. Directly comparable to Ecolyse's energy-focused microbiological products and similar in its use of engineered microbial platforms.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Ecolyse social profiles

Digital presence

Ecolyse financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ecolyse leadership team

Management profile

Number of profiles

Ecolyse funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ecolyse M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ecolyse

What does Ecolyse do?

Ecolyse offers microbiological products and services for the energy, industrial, and health sectors. The company develops and delivers biological/microbe-based solutions applicable across energy, industrial, and healthcare markets, leveraging microbial science to address sector-specific needs.

When was Ecolyse founded?

Ecolyse was founded in 2007. It employs 11 to 50 people.

Where is Ecolyse based?

Ecolyse is headquartered in College Station, United States, in the North America region.

Who are Ecolyse's main competitors?

Broad incumbents on record are Novonesis (formerly Novozymes), DSM-Firmenich, IFF (International Flavors & Fragrances) and Ginkgo Bioworks. Emerging players are BioVectra, Eligo Bioscience and Zymergen (now part of Ginkgo Bioworks). Amyris is listed as an others. Direct peers are Codexis and LanzaTech.

Does Ecolyse have an API?

No public API is recorded for Ecolyse.

What industry is Ecolyse in?

Ecolyse's product category is Industrial Microbiology / Bioremediation. Its primary akta.pro industry code is EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales